Primary Catalyst Driving Prenatal Testing & Newborn Screening Market Evolution in 2025: High Prevalence Of Genetic Diseases In Infants Fuels The Growth Of Prenatal Testing And Newborn Screening Market Driver

What Is the Future Outlook for the Prenatal Testing & Newborn Screening Market's Size and Growth Rate?
The market for prenatal testing and newborn screening has swiftly expanded in previous years. A rise from $6.24 billion in 2024 to $6.99 billion in 2025 is expected, showcasing a compound annual growth rate (CAGR) of 12.0%. Factors contributing to the growth during the historical period include progression in genetic testing, an uptick in maternal age, increased awareness and education, and changes in healthcare policy and regulations.

The market size for prenatal testing and newborn screening is predicted to undergo rapid expansion in the coming years, reaching a value of $11.08 billion in 2029 with a compound annual growth rate (CAGR) of 12.2%. The growth during the forecasted period can be linked to factors such as genetic counseling, advancements in technology, point-of-care testing, telehealth, and remote monitoring. Key trends expected in the forecast period encompass non-invasive prenatal testing (nipt), preimplantation genetic testing (pgt), telemedicine consultations, maternal blood testing, hemoglobinopathies, and screening for sickle cell disease.

What Is Stimulating Growth in the Prenatal Testing & Newborn Screening Market?
The increase of genetic diseases among newborns has played a significant role in boosting the prenatal testing & newborn screening market. The World Health Organization identifies these genetic diseases as including conditions like Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington's disease. Sickle cell anemia predominantly impacts millions worldwide, especially those with lineage from Africa, America, Cuba, Central America, Saudi Arabia, and India. A study conducted by Rady Children's Institute for Genomic Medicine, a well-known US-based research institute, in their hospital in February 2023, unveiled that single-locus (Mendelian) genetic diseases were responsible for 41% of infant deaths. Therefore, this high occurrence of genetic diseases among infants has catalyzed an increased demand and subsequently growth of the prenatal testing and newborn screening market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp

Which Key Market Leaders Are Driving Prenatal Testing & Newborn Screening Industry Growth?
Major companies operating in the prenatal testing & newborn screening market include PerkinElmer Inc., Laboratory Corporation of America Holdings (LabCorp), Natera Inc., Invitae Corporation, Centogene AG, Cradle Genomics Inc., Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc., Progenity Inc., Ravgen Inc., Strand Life Sciences Pvt. Ltd., Eurofins Scientific, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., General Electric Company, Siemens Healthineers AG, BGI Group, QIAGEN N.V., Veracyte Inc., NIPD Genetics, Novacyt UK, Ariosa Diagnostics Inc., Verinata Health Inc., Counsyl a Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid a Danaher Company, Guardant Health Inc., Genetron Health (Beijing) Co. Ltd.

What Are the Emerging Trends in the Prenatal Testing & Newborn Screening Industry?
Leading firms in the prenatal testing and newborn screening market are launching innovative programs that use rWGS (rapid Whole Genome Sequencing) technology to swiftly and precisely identify genetic disorders in newborn babies, thus facilitating early detection and intervention to enhance health outcomes. The rWGS technology is a sophisticated genomic method that instantaneously sequences the complete genome of a person. It differs from conventional genetic testing approaches that only target particular genes or areas, as rWGS captures the entirety of a person's DNA to pinpoint genetic variants associated with diseases or conditions. For instance, Rady Children's Institute for Genomic Medicine, a company based in the US, launched a pioneering program called BeginNGS in June 2022. The goal of this initiative is to detect and diagnose around 400 genetic disorders with known therapeutic solutions before symptoms become apparent. BeginNGS is honing genomic sequencing procedures with the aim of increasing testing capacity to include about 1,000 disorders. The ultimate objective is to facilitate screening for 3.7 million newborns each year, in the hopes of making it a common practice in hospitals throughout the nation.

What Are the Main Segments in the Prenatal Testing & Newborn Screening Market?
The prenatal testing & newborn screening market covered in this report is segmented -

1) By Diagnostic Type: Non-Invasive, Invasive
2) By Technology: Screening Technology, Diagnostic Technology
3) By End user: Hospitals, Diagnostic centers

Subsegments:
1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing), Ultrasound, Maternal Serum Screening
2) By Invasive: Amniocentesis, Chorionic Villus Sampling (CVS), Cordocentesis

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

Which Geographic Area Leads the Prenatal Testing & Newborn Screening Market?
North America was the largest region in the prenatal testing & newborn screening market in 2023. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Is Covered In The Prenatal Testing & Newborn Screening Global Market Report?

- Market Size Analysis: Analyze the Prenatal Testing & Newborn Screening Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Prenatal Testing & Newborn Screening Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Prenatal Testing & Newborn Screening Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Prenatal Testing & Newborn Screening Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3350

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.